IP Library › Assignment 023510/0243
Patent Assignment
Reel/Frame 023510/0243

Grant of Patent Security Interest

Recorded: 2009-11-12 Received: 2009-11-12 Pages: 14
Assignor
Assignee
SAGA INVESTMENTS LLC
C/O O'MELVENY & MYERS LLP, 2765 SAND HILL ROAD, MENLO PARK, CA, 94025, UNITED STATES
Covered Properties (68)
Suspension Actuator for a Roll Control System
Application: 12/303,328 →
Genetic Susceptibility Variants of Type 2 Diabetes Mellitus
Application: 12/442,233 →
Process for Preparing 4-((S)-2-(4-(4-Chlorophenoxy)Phenoxymethyl)Pyrrolidin-1-Yl)Butyric Acid Salts
Application: 61/228,315 →
Biaryl Substituted Nitrogen Containing Heterocycle Inhibitors of LTA4H for Treating Inflammation
Application: 12/472,958 →
Genetic Variants Contributing to Risk of Prostate Cancer
Application: 12/442,171 →
Cancer Susceptibility Variants on CHR8Q24.21
Application: 12/442,254 →
Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
Application: 11/913,807 →
Genetic Variants as Markers for Use in Diagnosis, Prognosis and Treatment of Eosinophilia, Asthma, and Myocardial Infarction
Application: 61/122,267 →
Genetic Susceptibility Variants Associated with Cardiovascular Disease
Application: 12/302,538 →
Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
Application: 12/315,114 →
Genetic Markers for Risk Management of Atrial Fibrillation, Atrial Flutter, and Stroke
Application: 12/302,463 →
Genetic Variants on CHR2 and CHR16 as Markers for Use in Breast Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
Application: 12/302,473 →
Substituted Aza-Bridged Bicyclics for Cardiovascular and Cns Disease
Application: 61/116,569 →
4- (or 5-) Substituted Catechol Derivatives
Application: 12/275,168 →
Biaryl PDE4 Inhibitors for Treating Pulmonary and Cardiovascular Disorders
Application: 12/275,152 →
Substituted Benzoazole PDE4 Inhibitors for Treating Inflammatory, Cardiovascular and Cns Disorders
Application: 12/275,165 →
PDE4 Inhibitors Selective for the Long Form of PDE4 for Treating Inflammation and Avoiding Side Effects
Application: 61/116,572 →
Biaryl PDE4 Inhibitors for Treating Inflammatory, Cardiovascular and Cns Disorders
Application: 12/275,163 →
Substituted Benzoxazole and Benzothiazole PDE4 Inhibitors for Treating Pulmonary and Cardiovascular Disorders
Application: 12/275,164 →
Aryl Sulfonamide Peri-Substituted Bicyclics for Occlusive Artery Disease
Application: 12/264,053 →
Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy
Application: 11/912,248 →
Genetic Variants on Chr 15Q24 as Markers for Use in Diagnosis, Prognosis and Treatment of Exfoliation Syndrome and Glaucoma
Application: 12/139,374 →
Biaryl Substituted Heterocycle Inhibitors of LTA4H for Treating Inflammation
Application: 12/136,874 →
Variants at chr8q24.21 confer risk of cancer
Application: 11/920,590 →
Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
Application: 10/587,412 →
Aryl Amino Acid Derivatives as Inhibitors for Treating Inflammation
Application: 11/833,382 →
Pyrazolylphenyl and Pyrrolylphenyl Inhibitors of LTA4H for Treating Inflammation
Application: 11/833,313 →
Phenoxymethylalkyne Inhibitors of LTA4H for Treating Inflammation
Application: 11/832,816 →
Methods for Producing Ex Vivo Models for Inflammatory Disease and Uses Thereof
Application: 11/879,066 →
Association of gene expression and psychiatric disoders
Application: 11/663,231 →
7-(Acryloyl) Indole Compositions and Methods of Making and Using Same
Application: 11/748,897 →
Process for Preparing 7-(Acryloyl)Indoles
Application: 11/748,858 →
Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
Application: 11/592,699 →
Electronic Enclosure with Continuous Ground Contact Surface
Application: 11/523,985 →
Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer
Application: 11/515,368 →
N-Linked Aryl Heteroaryl Inhibitors of LTA4H for Treating Inflammation
Application: 11/462,263 →
Biaryl Substituted Nitrogen Containing Heterocycle Inhibitors of LTA4H for Treating Inflammation
Application: 11/462,296 →
Biaryl Nitrogen-Heterocycle Inhibitors of LTA4H for Treating Inflammation
Application: 11/462,278 →
Biaryl Substituted Heterocycle Inhibitors of LTA4H for Treating Inflammation
Application: 11/426,287 →
Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes Mellitus
Application: 11/454,296 →
Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy
Application: 11/407,458 →
Inversion on chromosome 8p23 is a risk factor for anxiety disorders, depression and bipolar disorders
Application: 10/571,865 →
Methods of Diagnosing Susceptibility to Myocardial Infarction and Screening for an LTA4H Haplotype
Application: 11/270,804 →
Human type II diabetes gene-slit-3 located on chromosome 5q35
Application: 10/533,365 →
Carboxylic Acid Peri-Substituted Bicyclics for Occlusive Artery Disease
Application: 11/247,431 →
Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association
Application: 11/185,033 →
Sulfonamide Peri-Substituted Bicyclics for Occlusive Artery Disease
Application: 11/169,161 →
Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
Application: 11/096,191 →
Susceptibility Gene for Myocardial Infraction, Stroke, Poad; Methods of Treatment
Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association
Application: 11/043,752 →
Methods for Producing Ex Vivo Models for Inflammatory Disease and Uses Thereof
Application: 11/022,564 →
Human Type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
Application: 10/976,368 →
Use of 5-Lipoxygenase Activating Protein (Flap) Gene to Assess Susceptibility for Myocardial Infarction
Application: 10/829,674 →
Susceptibility gene for myocardial infarction and stroke
Application: 10/769,542 →
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
Application: 10/769,744 →
Human Type Ii Diabetes Gen-Kv Channel-Interacting Protein (KCHIP1) Located on Chromosome 5
Susceptibility Gene for Myocardial Infarction
Method and System for Defining Sets by Querying Relational Data Using a Set Definition Language
Application: 10/603,112 →
Indexing, Rewriting and Efficient Querying of Relations Referencing Semistructured Data
Application: 10/316,986 →
Human type II diabetes gene-SLIT-3 located on chromosome 5q35
Application: 60/423,541 →
Methods for Predicting Drug Sensitivity in Patients Afflicted with an Inflammatory Disease
Application: 10/234,652 →
Populating Data Cubes Using Calculated Relations
Application: 10/216,670 →
Neuregulin-1 Transgenic Mouse and Methods of Use
Application: 10/107,604 →
Inference Control Method in a Data Cube
Application: 10/057,314 →
Methods for Predicting Drug Sensitivity in Patients Afflicted with an Inflammatory Disease
Application: 09/947,991 →
Methods for Producing Ex Vivo Models for Inflammatory Disease and Uses Thereof
Application: 09/947,954 →
Human schizophrenia gene
Application: 09/946,807 →
Automatic Identity Protection System with Remote Third Party Monitoring
Application: 09/808,720 →